References
- Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 1997;19:310–27
- Dorjgochoo T, Deming SL, Gao YT. History of benign breast disease and risk of breast cancer among women in China: a case-control study. Cancer Cause Control 2008;19:819–28
- Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 2006;11:435–49
- Blumel JE, Chedraui P, Baron G, et al. Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Climacteric 2012;15:542–51
- Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 2003;27:836–41
- Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229–37
- Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146–51
- Alipour S, Jafari-Adli S, Eskandari A. Benefits and harms of phytoestrogen consumption in breast cancer survivors. Asian Pac J Cancer P 2015;16:3091–396
- Tao M, Shao H, Li C, Teng Y. Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Preference and Adherence 2013;7:223–9
- Kupperman HS, Blatt MH, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 1953;13:688–703
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012;97:1159–68
- Chou MF, Wun YT, Pang SM. Menopausal symptoms and the menopausal rating scale among midlife chinese women in Macau, China. Women Health 2014;54:115–26
- Islam MR, Gartoulla P, Bell RJ, Fradkin P, Davis SR. Prevalence of menopausal symptoms in Asian midlife women: a systematic review. Climacteric 2015;18:157–76
- Shea JL. Chinese women's symptoms: relation to menopause, age and related attitudes. Climacteric 2006;9:30–9
- Yang D, Haines CJ, Pan P, et al. Menopausal symptoms in mid-life women in southern China. Climacteric 2008;11:329–36
- Genazzani AR, Schneider HP, Panay N, Nijland EA. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 2006;22:369–75
- Huang KE, Xu L, I NN, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010;65:276–83
- Williams RE, Kalilani L, DiBenedetti DB, et al. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas 2007;58:348–58
- Velasco-Murillo V, Navarrete-Hernández E, Ojeda-Mijares RI, et al. [Experience and knowledge about climateric and menopause in women in Mexico City]. Gaceta Medica de Mexico 2000;136:555–64
- Strothmann A, Schneider HP. Hormone therapy: the European women's perspective. Climacteric 2003;6:337–46
- Sturdee DW, Pines A, Archer DF. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20
- de Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37